DKDogan Kaymaz

Dogan Kaymaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dogan Kaymaz has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Spondylometaepiphyseal Dysplasia, Short Limb Type: A Novel Nonsense DDR2 Variant and Renal Involvement in a Neonatal Case

    by Canberk Akbaba, Aysenur Atan Kilic, Muhammed Dogukan Kalenderoglu, Ferhan Demirtas, Dogan Kaymaz, Emel Okulu, Ömer Erdeve, Begum Atasay

  • A Tiered Genetic Diagnostic Approach in Newborns With Major Congenital Anomalies: Experience From a Tertiary NICU

    by Hatice Mutlu, Ece Eker, Yasemin Ezgi Köstekci, Ferhan Demirtaş, Doğan Kaymaz, Muhammed Doğukan Kalenderoğlu, Arzu Ay, Şule Altıner, Emel Okulu, Ömer Erdeve, et al.

    Background: Major congenital anomalies (MCAs) are a leading cause of neonatal morbidity and mortality and frequently reflect underlying chromosomal, copy number, or single‐gene defects. In neonates with multiple MCAs, early molecular diagnosis is critical but remains challenging due to phenotypic heterogeneity, overlapping developmental pathways, and limitations in selecting the most appropriate genetic test. Methods: This prospective study included 146 neonates with congenital anomalies who were referred for genetic consultation from a tertiary neonatal intensive care unit between April 2022 and May 2025. A major congenital anomaly was defined as a structural abnormality present at birth with significant medical, functional, or cosmetic consequences, while multiple congenital anomalies were defined as two or more major anomalies involving different organ systems. Clinical features were systematically annotated using Human Phenotype Ontology terms and classified according to organ system and embryological origin. A tiered diagnostic strategy was applied, including conventional cytogenetic analysis, chromosomal microarray analysis (CMA), whole‐exome sequencing (WES), and rapid‐WES (rWES) in selected critically ill neonates. Results: Cardiovascular anomalies were the most frequent (45.9%), and 88 of 146 neonates (60.3%) had two or more MCAs. Cytogenetic testing identified numerical chromosomal abnormalities in eight neonates. CMA detected pathogenic or likely pathogenic copy number variants in 6 of 65 tested cases (9.1%). In CMA‐negative patients, WES achieved a diagnostic yield of 41.4%, identifying variants in genes involved in multisystem developmental pathways. Rapid WES established definitive molecular diagnoses in two of three critically ill neonates within 72 h, directly influencing clinical management. Embryological analysis revealed recurrent co‐occurrence patterns, particularly cardiovascular–craniofacial and cardiovascular–genitourinary associations. Conclusion: A structured, tiered genomic approach enhances diagnostic yield in neonates with congenital anomalies. Integration of cytogenetics, CMA, and CNV‐aware exome sequencing provides a pragmatic and clinically actionable framework for molecular diagnosis in NICU settings and supports developmentally informed interpretation of complex phenotypes.

  • Open Access

    Balancing Overtreatment and Safety: Impact of 2023 Guideline Change on Antibiotic Use in Late Preterm Infants

    by Dogan Kaymaz, Deniz Uzun, Ferhan Demirtas, Yasemin Ezgi Kostekci, Emel Okulu, Omer Erdeve, Begum Atasay, Saadet Arsan

    Objective: To evaluate the impact of the 2023 national guideline revision, which increased the gestational age threshold for empirical antibiotic initiation from <34 to <35 weeks, on hospitalization and antibiotic exposure in infants born at 340/7-346/7 weeks. Materials and Methods: This single-center retrospective cohort study included all live-born infants at 340/7-346/7 weeks between April 2018 and September 2023. The same cohort was reassessed according to the 2018 and 2023 Turkish Neonatology Society’s national guidelines on the Diagnosis and Treatment of Neonatal Infections criteria. For each infant, neonatal intensive care unit (NICU) admission, empirical antibiotic use, and hospitalization duration were recalculated under both scenarios. Results: A total of 272 infants were included. Under the 2018 guideline, 68 infants (25.0%) required empirical antibiotics, whereas the 2023 guideline classified 197 infants (72.4%) as needing treatment, adding 129 newly eligible infants. Among these, 66 infants who had previously roomed-in required new NICU admission, increasing total admissions from 183 (67.3%) to 249 (91.5%). Median antibiotic duration increased from 0 days to 2 days, and median hospitalization increased from 5 to 6 days (both P < .001). None of the newly classified infants developed clinical or culture-proven early-onset neonatal sepsis (EONS). Conclusion: Raising the gestational age threshold to <35 weeks substantially increased empirical antibiotic use and NICU admissions without improving EONS detection. These findings highlight the need for more refined and clinically integrated risk-stratification strategies and underscore the broader implications of unnecessary antibiotic exposure, including increased NICU utilization, healthcare burden, and antimicrobial stewardship concerns.

  • Open Access

    An Infant with Extubation Failure: A Case Report of Esophageal Atresia with Type-4 Laryngotracheoesophageal Cleft

    by Esin Gizem Olgun, Mukaddes Ağırtıcı, Semra Küçük Öztürk, Doğan Kaymaz, Merve Havan, Ergün Ergün, Çiler Büyükatalay, Emel Okulu, Tanıl Kendirli, Nazan Çobanoğlu